Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-18

Clinical Trial Update: A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for bimatoprost in primary open-angle glaucoma and ocular hypertension completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-06-18